Difference between revisions of "Jeffrey Chuang"

From Chuang Lab
Jump to: navigation, search
Line 1: Line 1:
 
[[File:130px-Jeff_Chuang_2-2014.jpg]]
 
[[File:130px-Jeff_Chuang_2-2014.jpg]]
  
My scientific career has explored the intersections of mathematical modeling, molecular biology, and computational data science. I received my BA in Chemistry and Physics from Harvard in 1996, followed by a Ph.D. in theoretical physics at MIT in 2001, where I studied protein folding, DNA biophysics, and the statistical mechanics of polymer gels with Toyoichi Tanaka, Alexander Grosberg, and Mehran Kardar.  I changed fields to computational biology during my postdoc at UC San Francisco with [http://mobydick.ucsf.edu/ Prof. Hao Li] in the Biochemistry and Biophysics Department. There I trained in the molecular evolution of genomes and gene regulatory processes. From 2005-2012 I was an assistant professor in the Biology Department at Boston College. I joined the Jackson Laboratory for Genomic Medicine as an Associate Professor in Fall 2012, where my major interests have been cancer genomics, intratumoral evolution, and RNA-level gene regulation. I also have longtime interests in science communication and education, developed out my work as a AAAS Mass Media Fellow during graduate school. My group has been supported by organizations including the National Institutes of Health (NCI, NHGRI, NINDS), the National Science Foundation, the Hope Foundation, and the PhRMA Foundation.
+
My scientific career has explored the intersections of mathematical modeling, molecular biology, and computational data science. I received my BA in Chemistry and Physics from Harvard in 1996, followed by a Ph.D. in theoretical physics at MIT in 2001, where I studied protein folding, DNA biophysics, and the statistical mechanics of polymer gels with Toyoichi Tanaka, Alexander Grosberg, and Mehran Kardar.  I changed fields to computational biology during my postdoc at UC San Francisco with [http://mobydick.ucsf.edu/ Prof. Hao Li] in the Biochemistry and Biophysics Department. There I trained in the molecular evolution of genomes and gene regulatory processes. From 2005-2012 I was an assistant professor in the Biology Department at Boston College. I joined the Jackson Laboratory for Genomic Medicine as an Associate Professor in Fall 2012, where my major interests have been cancer genomics, intratumoral evolution, and RNA-level gene regulation. I also have longtime interests in science communication and education, developed originally out my work as a AAAS Mass Media Fellow during graduate school. My group has been supported by organizations including the National Institutes of Health (NCI, NHGRI, NINDS), the National Science Foundation, the Hope Foundation, and the PhRMA Foundation.

Revision as of 08:00, 4 June 2018

130px-Jeff Chuang 2-2014.jpg

My scientific career has explored the intersections of mathematical modeling, molecular biology, and computational data science. I received my BA in Chemistry and Physics from Harvard in 1996, followed by a Ph.D. in theoretical physics at MIT in 2001, where I studied protein folding, DNA biophysics, and the statistical mechanics of polymer gels with Toyoichi Tanaka, Alexander Grosberg, and Mehran Kardar. I changed fields to computational biology during my postdoc at UC San Francisco with Prof. Hao Li in the Biochemistry and Biophysics Department. There I trained in the molecular evolution of genomes and gene regulatory processes. From 2005-2012 I was an assistant professor in the Biology Department at Boston College. I joined the Jackson Laboratory for Genomic Medicine as an Associate Professor in Fall 2012, where my major interests have been cancer genomics, intratumoral evolution, and RNA-level gene regulation. I also have longtime interests in science communication and education, developed originally out my work as a AAAS Mass Media Fellow during graduate school. My group has been supported by organizations including the National Institutes of Health (NCI, NHGRI, NINDS), the National Science Foundation, the Hope Foundation, and the PhRMA Foundation.